Brainstorm Cell Therapeutics Inc. (BCLI)의 가격은 얼마입니까?

Brainstorm Cell Therapeutics Inc. (BCLI)의 가격은 $1.10입니다.

Brainstorm Cell Therapeutics Inc. (BCLI)의 시가 총액은 무엇입니까?

Brainstorm Cell Therapeutics Inc. (BCLI)의 시가 총액은 $12.14M입니다.

Brainstorm Cell Therapeutics Inc. (BCLI) 배당수익률

Brainstorm Cell Therapeutics Inc. (BCLI) is a biotechnology firm dedicated to the development and commercialization of personalized, autologous cellular therapies. These innovative treatments are specifically designed to address neurodegenerative diseases. At the heart of its strategy is the proprietary NurOwn cell therapy platform. This platform employs sophisticated cell culture techniques to prompt mesenchymal stem cells, derived from the patient's own bone marrow, to produce high concentrations of neurotrophic factors. This process aims to regulate neuroinflammatory and neurodegenerative disease mechanisms, bolster the survival of neurons, and ultimately enhance neurological function. NurOwn is currently undergoing significant clinical development, having completed a Phase III clinical trial for Amyotrophic Lateral Sclerosis (ALS). Additionally, it has successfully advanced through Phase II clinical trials for both progressive multiple sclerosis and Alzheimer's disease, with potential applications being explored for other neurodegenerative conditions. To support its therapeutic pipeline, the company has established a manufacturing partnership with Catalent for NurOwn. Incorporated in 2000, the company initially operated as Golden Hand Resources Inc. before adopting the name Brainstorm Cell Therapeutics Inc. in November 2004. Its corporate headquarters are situated in New York, New York.

연도	배당 수익률	변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

배당 수익률

변화

제공된 날짜에 대한 데이터가 충분하지 않습니다.

회사	배당 수익률	국가
Vertex Pharmaceuticals Incorporated VRTX.US	0.00%	US
Argenx SE ARGX.US	0.00%	NL
CSL Limited CSL.AX	3.12%	AU
Lonza Group AG LONN.SW	0.00%	CH
Samsung Biologics Co.,Ltd. 207940.KS	0.00%	KR

회사

배당 수익률

국가